What Is Zomacton Used For?
Zomacton (somatropin) is a recombinant human growth hormone approved by the FDA for treating growth failure in children due to growth hormone deficiency (GHD), idiopathic short stature, or conditions like Turner syndrome, Prader-Willi syndrome, and chronic kidney disease.[1] It replaces deficient growth hormone to promote linear growth in height.
How Does It Promote Growth?
Zomacton mimics natural growth hormone, stimulating cartilage growth in long bones, increasing protein synthesis, and enhancing IGF-1 production, which drives bone elongation during childhood.[1][2] Clinical trials show children with GHD gaining 3-4 inches more height over 1-2 years compared to untreated peers.[2]
Who Qualifies for Zomacton Treatment?
Eligible children typically have:
- Confirmed GHD via stimulation tests.
- Height below the 3rd percentile for age/sex.
- Open growth plates (pre-puberty).
Dosing starts at 0.16-0.24 mg/kg weekly via subcutaneous injection, adjusted by blood tests.[1]
What Happens If Used Off-Label for Growth?
Not approved for healthy short children without deficiency or post-puberty height enhancement. Risks include joint pain, diabetes, scoliosis worsening, and rare intracranial hypertension.[1] Pediatric endocrinologists screen rigorously to avoid misuse.
When Does Treatment End?
Therapy stops at growth plate closure (bone age ~14-16 years in girls, 16-18 in boys), confirmed by X-ray. Average final height gain: 2-4 inches in GHD cases.[2]
Cost and Access for Growth Treatment
Monthly cost ranges $1,000-$2,000 without insurance; most plans cover for FDA-approved uses with prior authorization.[3] Ferring Pharmaceuticals manufactures it; no generic somatropin biosimilars compete directly yet.
Alternatives to Zomacton for Short Stature
- Other GH brands: Norditropin, Genotropin, Humatrope—similar efficacy, differ in delivery devices.[2]
- Non-GH options: Aromatase inhibitors (off-label) or letrozole to delay puberty, adding ~1-2 inches.[4]
- No treatment: Monitoring for idiopathic cases, as 90%+ reach normal adult height naturally.[4]
[1] FDA Label: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103884s056lbl.pdf
[2] Endocrine Society Guidelines: https://academic.oup.com/jcem/article/102/10/3446/4092336
[3] Drugs.com Pricing: https://www.drugs.com/price-guide/zomacton
[4] Pediatric Growth Hormone Review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266867/